This inventor holds 22 USPTO granted patents and 15 published patent applications and 2 EPO patents. Top assignees: Case Western Reserve University, Kent State University, Northwestern University. Active years: 2011-2026.
Location History:
- Shaker Heights, OH (US) (2011 - 2024)
- Cleveland, OH (US) (2018 - 2024)
Company Filing History:
22 out of 1,363 
1 out of 230 
1 out of 2,213 
Years Active: 2011-2026
Title: The Innovative Mind of James P Basilion
Introduction
James P Basilion, based in Shaker Heights, OH, is a prominent inventor with a remarkable portfolio of 20 patents. His work primarily focuses on developing targeted pharmaceutical compounds for the treatment and detection of cancers, showcasing his commitment to advancing medical science.
Latest Patents
Among his latest innovations are the patents for PSMA targeted conjugate compounds and their applications. These compounds are designed to improve the efficacy of cancer treatment by enabling targeted delivery and detection. The first patent outlines methods for treating and identifying cancer cells, while the second focuses on prostate-specific membrane antigen (PSMA) targeted compounds, including their formation into nanoclusters and implications for pharmaceutical compositions.
Career Highlights
Throughout his career, James P Basilion has contributed significantly to research and innovation in the biomedical field. He has held positions at prestigious institutions such as Case Western Reserve University and Kent State University, where he has been instrumental in fostering an environment conducive to groundbreaking research.
Collaborations
Collaboration plays a critical role in Basilion's work, as evidenced by his partnerships with notable colleagues like Xinning Wang and Clemens Burda. Together, they have worked on various projects that have pushed the boundaries of medical research and innovation, leading to advancements in cancer treatment methodologies.
Conclusion
James P Basilion stands out as a visionary inventor in the realm of cancer research. With a strong portfolio of patents and a commitment to collaboration within the academic community, he continues to pave the way for innovations that have the potential to positively impact countless lives through improved cancer treatments and detection methods.